Mobile Health Tool for Concussions
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new mobile health tool designed to help young people recover more quickly from concussions. Known as mHealth assisted specialist access, the tool connects patients from the emergency department to specialized concussion care, aiming to improve access and reduce recovery time. The trial suits teens aged 13-18 who have recently had a concussion, visit the Children's Hospital of Philadelphia, and have a smartphone. Participants must be at moderate-to-high risk for prolonged symptoms following their concussion. As an unphased trial, this study offers a unique opportunity for participants to contribute to innovative research that could enhance concussion recovery for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this mobile health tool is safe for concussed youth?
Research has shown that mobile health (mHealth) tools, like the one used in this study, are generally safe and easy to use. A review of studies found that mHealth technology can effectively track patient-reported outcomes without major safety concerns. People can use these tools to report symptoms and activities with little risk of negative effects.
In studies on remote monitoring for concussions, researchers found no major safety issues. Participants typically use chat technology to share daily symptoms, which helps them receive necessary care without physical procedures. This virtual approach reduces the chance of physical side effects.
Overall, mHealth technology has proven safe in similar situations, making it a promising option for improving access to care with minimal risk.12345Why are researchers excited about this trial?
Researchers are excited about the mobile health tool for concussions because it offers a new way to connect concussed youth at risk for prolonged symptoms with specialist care. Unlike traditional treatments that often involve in-person visits and lengthy wait times, this approach leverages mobile technology to provide more immediate access to healthcare professionals. This could lead to faster assessments and more personalized care, potentially reducing the duration and severity of concussion symptoms.
What evidence suggests that this mobile health tool is effective for concussions?
Research has shown that mobile health (mHealth) tools can assist people with traumatic brain injuries (TBI), such as concussions, in managing symptoms and improving recovery. In this trial, participants will use mHealth-assisted specialist access to track symptoms and manage care. Studies have found that digital tools for tracking symptoms in individuals with mild TBI are practical and can ease recovery. mHealth technology encourages daily reporting of symptoms and activities, facilitating faster access to appropriate care. This approach can lead to quicker recovery by ensuring timely specialist visits. Additionally, it offers an affordable and efficient way to manage patient care.12367
Who Is on the Research Team?
Daniel J Corwin, MD, MSCE
Principal Investigator
Children's Hospital of Philadelphia
Are You a Good Fit for This Trial?
This trial is for 13-18 year olds who've had a concussion and are at moderate-to-high risk of long-term symptoms. They must have been to the Children's Hospital of Philadelphia within 72 hours of injury, own a smartphone, and meet specific medical criteria for concussion severity.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use remote patient monitoring (RPM) to report symptoms and activity daily, facilitating care hand-off from the emergency department to concussion specialty care
Follow-up
Participants are monitored for persistent post-concussion symptoms and recovery milestones
Long-term follow-up
Evaluation of patient-defined and provider-defined appropriateness and acceptability of the intervention
What Are the Treatments Tested in This Trial?
Interventions
- mHealth assisted specialist access
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital of Philadelphia
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator